PPARG and pulmonary arterial hypertension: In PAH, reduced mitochondrial FAO in RV cardiomyocytes is primarily due to decreased PPARγ activity and significant downregulation of key FAO genes CPT1b and FABP4, shifting energy metabolism from efficient FAO to inefficient glycolysis, resulting in insufficient ATP production and exacerbating mitochondrial dysfunction [78].